RZNOMICS - Trademark Details
Status: 700 - Registered
Serial Number
79300505
Registration Number
6585436
Word Mark
RZNOMICS
Status
700 - Registered
Status Date
2021-12-14
Filing Date
2020-11-13
Registration Number
6585436
Registration Date
2021-12-14
Mark Drawing
3000 - Illustration: Drawing or design which also includes word(s)/ letter(s)/number(s)
Typeset
Design Searches
260121, 260129, 261709, 270301 - Circles that are totally or partially shaded. Helixes. Curved line(s), band(s) or bar(s). Geometric figures forming letters or numerals, including punctuation.
Published for Opposition Date
2021-09-28
Attorney Name
Law Office Assigned Location Code
M80
Employee Name
FOSTER, ALEXANDRA M.
Statements
Indication of Colors claimed
The color(s) gray, red, yellow and light gray is/are claimed as a feature of the mark.
Desription of the Colors Claimed
In the alphabet of "Rznomics", "i" is represented by red, yellow, gray, and light gray DNA shapes, "z" is red, and all other letters are gray.
Description of Mark
The mark consists of the stylized wording "RZNOMICS" with "R", "NOM", and "CS" in grey, "Z" in red, and the "I" being formed by a grey, yellow, light grey, and red helix with a red circle forming the dot.
Goods and Services
Ophthalmic preparations; pharmaceutical products for the treatment of viral and infectious disease, for the treatment of cancer; pharmaceutical products for the treatment of cancer; pharmaceuticals for the treatment of cancer disease, neurodegenerative disease, neurodevelopmental disorder, eye disease, muscular disease, infectious disease, cardiovascular disease, gastrointestinal disease, blood disease, metabolic disease, immune disease, genetic disease; pharmaceutical preparations acting on the central nervous system for the treatment of dementia, Alzheimer's disease, Parkinson's disease, Huntington's disease, neuromuscular disorders, neurodevelopmental disorders, neurovascular disease; anti-cancer preparations; cardiovascular pharmaceuticals; pharmaceutical preparations for immunity adjustment; pharmaceutical preparations for the use in hematology; anti-diabetic pharmaceuticals; pharmaceutical products for the treatment of infectious disease; anti-dermoinfectives; pharmaceutical preparations for the treatment of kidney disease; pharmaceutical agents affecting peripheral nervous system; pharmaceutical preparations in the nature of autonomic drugs for medical purposes; pharmaceutical products for treating respiratory disease; pharmaceutical preparations for treating epidermal problems; viral vaccines; anti-viral agents, namely, anti-viral disinfectants; pharmaceutical and veterinary preparations for the treatment of cancer disease, neurodegenerative disease, eye disease, muscular disease, infectious disease, cardiovascular disease, gastrointestinal disease, blood disease, metabolic disease, immune disease, genetic disease
Goods and Services
Research and development of vaccines and medicines; drug discovery services; scientific research for medical purposes in the field of cancerous disease; scientific research for medical purposes in the area of cancerous disease; research and development in the fields of pharmaceutical and biotechnology; testing, inspection or research of pharmaceuticals, cosmetics or foodstuff; pharmaceutical products development; research on the subject of pharmaceuticals; clinical studies of medicines, namely, clinical research in the field of cancer therapy, neurodegenerative disease therapy, neurodevelopmental disorder therapy, eye disease therapy, muscular disease therapy, infectious disease therapy, cardiovascular disease therapy, gastrointestinal disease therapy, blood disease therapy, metabolic disease therapy, immune disease therapy, genetic disease therapy, radiology, chemotherapy; medical research services for assessing the efficiency of pharmaceuticals; pharmaceutical drug development services; scientific research in the field of pharmacy; consultancy pertaining to pharmacology; medicine research, namely, research and development of vaccines and medicines; testing of pharmaceuticals; research in the field of medical products; providing information on the test, inspection, and research of medical products; consultation and providing information in the fields of pharmacology; industrial research in the fields of medicine, health and pharmacology; analysis of human tissues for medical research
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
005, 006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2020-12-29
Primary Code
005
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2020-12-29
Primary Code
042
Current Trademark Owners
Party Name
Party Type
30 - Original Registrant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Name
Party Type
30 - Original Registrant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
20 - Owner at Publication
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
10 - Original Applicant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Kisuk Lee
Address
Please log in with your Justia account to see this address.
International Registrations
International Registration Number
1566440
International Registration Date
2020-11-13
International Publication Date
2020-12-24
International Renewal Date
2030-11-13
Auto Protection Date
2022-06-24
International Status
001 - Request for extension of protection established
International Status Date
2020-12-24
Priority Claimed In
True
Priority Claimed Date
2020-11-12
First Refusal In
True
Trademark Events
Event Date | Event Description |
2020-12-24 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
2020-12-29 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
2021-01-02 | APPLICATION FILING RECEIPT MAILED |
2021-04-24 | ASSIGNED TO EXAMINER |
2021-04-27 | NON-FINAL ACTION WRITTEN |
2021-04-28 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
2021-04-28 | REFUSAL PROCESSED BY MPU |
2021-04-28 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
2021-05-23 | REFUSAL PROCESSED BY IB |
2021-08-23 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
2021-08-23 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
2021-08-23 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
2021-08-23 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
2021-08-23 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
2021-08-23 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
2021-08-23 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2021-08-24 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2021-08-24 | EXAMINERS AMENDMENT -WRITTEN |
2021-08-24 | EXAMINERS AMENDMENT E-MAILED |
2021-08-24 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
2021-08-24 | EXAMINER'S AMENDMENT ENTERED |
2021-08-24 | APPROVED FOR PUB - PRINCIPAL REGISTER |
2021-09-08 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
2021-09-28 | PUBLISHED FOR OPPOSITION |
2021-09-28 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
2021-11-12 | NEW REPRESENTATIVE AT IB RECEIVED |
2021-12-14 | REGISTERED-PRINCIPAL REGISTER |